BiotechTube

IVIG

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Myasthenia Gravid

Conditions

Myasthenia Gravid

Trial Timeline

Mar 1, 2007 → Jul 1, 2010

NCT ID
NCT01179893

About IVIG

IVIG is a approved stage product being developed by Grifols for Myasthenia Gravid. The current trial status is completed. This product is registered under clinical trial identifier NCT01179893. Target conditions include Myasthenia Gravid.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (4)

NCT IDPhaseStatus
NCT02043379Pre-clinicalCompleted
NCT01841619Phase 1Completed
NCT01179893ApprovedCompleted
NCT00115778Phase 2Completed

Competing Products

20 competing products in Myasthenia Gravid

See all competitors
ProductCompanyStageHype Score
SatralizumabChugai PharmaceuticalPhase 3
77
tacrolimusAstellas PharmaPhase 3
77
Tacrolimus capsule + PlaceboAstellas PharmaPhase 3
77
tacrolimus + placeboAstellas PharmaPhase 3
77
RavulizumabAstraZenecaPre-clinical
23
Cladribine Low Dose + Cladribine High DoseMerckPhase 3
77
Remibrutinib (Blinded) + Remibrutinib (Open Label)NovartisPhase 3
77
Placebo + CFZ533NovartisPhase 2
52
IptacopanNovartisPhase 3
77
mycophenolate mofetil [CellCept] + PlaceboRochePhase 3
77
mycophenolate mofetil (CellCept) + placeboRochePhase 3
77
inebilizumab + IV PlaceboAmgenPhase 3
76
InebilizumabAmgenPhase 2
51
Abatacept InjectionBristol Myers SquibbPhase 1
32
Tolebrutininb + PlaceboSanofiPhase 3
76
Pozelimab + Cemdisiran + Cemdisiran + PozelimabRegeneron PharmaceuticalsPhase 3
76
HIZENTRA ®CSLPhase 2
51
Subcutaneous immunoglobulinsCSLPhase 1
32
Human normal immunoglobulin G (IgG)CSLPhase 3
76
zilucoplan (RA101495)UCBPhase 3
74

Other Products from Grifols

Tetanus Immune Globulin (Human) + Diphtheria-Tetanus Toxoids AdsorbedApproved
82
Alphanate SD/HTApproved
82
(100 ml of Albumin 25%)Approved
82
FVIII + EmicizumabApproved
82
AlbuminApproved
82